J. A. Hoffmann

Modifications in the B10 and B26–30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor

L. Slieker, G. S. Brooke, R. DiMarchi, 1997, Diabetologia.

Structural requirements of pancreatic polypeptide receptor binding.

J. A. Hoffmann, R. Chance, R. Gingerich, 1991, The American journal of physiology.

Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics.

L. Slieker, G. S. Brooke, J. A. Hoffmann, 1993, Advances in experimental medicine and biology.

Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.

N. Seymour, H. Lebovitz, D. Andersen, 1996, The Journal of clinical endocrinology and metabolism.

Purification and analysis of the major components of chum salmon protamine contained in insulin formulations using high-performance liquid chromatography.

J. A. Hoffmann, R. Chance, M. Johnson, 1990, Protein expression and purification.

(A-C-B) human proinsulin, a novel insulin agonist and intermediate in the synthesis of biosynthetic human insulin.

L. Slieker, G. S. Brooke, J. A. Hoffmann, 1992, The Journal of biological chemistry.

Chemical, Physical, and Biologic Properties of Biosynthetic Human Insulin

J. A. Hoffmann, R. Chance, B. Frank, 1981, Diabetes Care.

Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.

N. Seymour, H. Lebovitz, D. Andersen, 1996, The Journal of clinical endocrinology and metabolism.